New vaccine trial for head and neck cancer patients
Patients in Birmingham who have advanced head and neck cancers may be eligible to take part in a new clinical trial of a potential cancer vaccine, supported by the NHS Cancer Vaccine Launch Pad (CVLP…
Birmingham academic appointed Clinical Lead of new NIHR network
The National Institute for Health and Care Research (NIHR) has awarded £6.5 million, funded jointly through a public-private partnership with the pharmaceutical industry, to establish a UK-wide Comme…
Adding dendritic cell vaccine to liver cancer therapy slows disease progression
Patients with intermediate-stage primary liver cancer who received a vaccine of dendritic cells (DC) alongside their cancer therapy saw a longer time without tumour progression in response to standar…
New trial to test novel diagnostic for bladder cancer recurrence
Nonacus, an early cancer testing company, has announced two West Midlands-based trials to assess a new way of monitoring for recurrence of bladder cancer, using a novel test developed in collaboratio…
Strict regulations needed to address commercial health self-test concerns
Far greater regulation is needed for off-the-shelf health tests, due to considerable concerns over both suitability of the tests for the public, and accuracy of claims made on-package.
In a serie…
Pardeep Janjua and Carlos Chan take home summer BHP People awards
July’s BHP People awards have been awarded to Pardeep Janjua, Research Data and Systems Officer at Sandwell and West Birmingham Hospitals (SWB) and Carlos Chan, Research Development Coordinator at th…